Abstract: The ongoing Covid-19 pandemic has inevitably changed the treatment of many chronic diseases which has been suspended or has suffered dangerous slowdowns. Osteoarthritis (OA) is the most common musculoskeletal disease. As a result, the medical management of Osteoarthritis was heavily impacted by the pandemic, and it required new therapeutic strategies. The purpose of this descriptive review is to provide an overview of how much the pandemic has affected the medical management of osteoarthritis and to outline a number of possible countermeasures. The COVID-19 pandemic requires a "multimodal approach": physicians are called to test the management of Osteoarthritis patients at a distance, through the tools made available by telemedicine, for all cases in which direct contact is avoidable. Therapies that instead require a direct intervention on the patient impose that all the procedures are carried out in complete safety, scrupulously keeping to the use of personal protective equipements.
La pandemia di Covid-19 in corso ha inevitabilmente cambiato il trattamento di molte malattie croniche che è stato sospeso o ha subito pericolosi rallentamenti. L’osteoartrosi (OA) è la malattia muscolo-scheletrica più comune. Di conseguenza, la gestione medica dell’OA è stata fortemente influenzata dalla pandemia e ha richiesto nuove strategie terapeutiche. Lo scopo di questo short paper è fornire una panoramica di come la pandemia ha influenzato la gestione medica dell’osteoartrosi e delineare una serie di possibili contromisure. La pandemia COVID-19 richiede un “approccio multimodale”: i medici sono chiamati a testare la gestione dei pazienti OA a distanza, attraverso gli strumenti messi a disposizione dalla telemedicina, per tutti i casi in cui il contatto diretto è evitabile. Le terapie che invece richiedono un trattamento diretto sul paziente impongono che tutte le procedure siano svolte in completa sicurezza, attenendosi scrupolosamente all’uso dei dispositivi di protezione individuale.
Medical management of osteoarthritis during the CO-VID-19 pandemic: a challenge for the present and the future / Bernetti, A.; Fari, G.; Mangone, M.; Fiore, P.; Santilli, V.; Paoloni, M.; Agostini, F.. - In: ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITÀ. - ISSN 1120-9135. - 34:2(2022), pp. 184-189. [10.7416/ai.2022.2478]
Medical management of osteoarthritis during the CO-VID-19 pandemic: a challenge for the present and the future
Bernetti A.;Mangone M.;Santilli V.;Paoloni M.;Agostini F.
2022
Abstract
Abstract: The ongoing Covid-19 pandemic has inevitably changed the treatment of many chronic diseases which has been suspended or has suffered dangerous slowdowns. Osteoarthritis (OA) is the most common musculoskeletal disease. As a result, the medical management of Osteoarthritis was heavily impacted by the pandemic, and it required new therapeutic strategies. The purpose of this descriptive review is to provide an overview of how much the pandemic has affected the medical management of osteoarthritis and to outline a number of possible countermeasures. The COVID-19 pandemic requires a "multimodal approach": physicians are called to test the management of Osteoarthritis patients at a distance, through the tools made available by telemedicine, for all cases in which direct contact is avoidable. Therapies that instead require a direct intervention on the patient impose that all the procedures are carried out in complete safety, scrupulously keeping to the use of personal protective equipements.File | Dimensione | Formato | |
---|---|---|---|
Bernetti_Medical_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
70.77 kB
Formato
Adobe PDF
|
70.77 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.